Literature DB >> 27352369

Cervical Spondylotic Myelopathy.

Aditya Iyer1, Tej D Azad, Suzanne Tharin.   

Abstract

Cervical spondylotic myelopathy (CSM) is a degenerative disease that represents the most common spinal cord disorder in adults. The natural history of the disease can be insidious, and patients often develop debilitating spasticity and weakness. Diagnosis includes a combination of physical examination and various imaging modalities. There are various surgical options for CSM, consisting of anterior and posterior procedures. This article summarizes the literature regarding the pathophysiology, natural history, and diagnosis of CSM, as well as the various treatment options and their associated risks and indications.

Entities:  

Mesh:

Year:  2016        PMID: 27352369     DOI: 10.1097/BSD.0000000000000397

Source DB:  PubMed          Journal:  Clin Spine Surg        ISSN: 2380-0186            Impact factor:   1.876


  25 in total

1.  Full endoscopic cervical spine surgery.

Authors:  Jian Shen; Albert E Telfeian; Elias Shaaya; Adetokunbo Oyelese; Jared Fridley; Ziya L Gokaslan
Journal:  J Spine Surg       Date:  2020-06

2.  Shikonin inhibits neuronal apoptosis via regulating endoplasmic reticulum stress in the rat model of double-level chronic cervical cord compression.

Authors:  Min Yao; Gan Li; Long-Yun Zhou; Zhong Zheng; Yue-Li Sun; Shu-Fen Liu; Yong-Jun Wang; Xue-Jun Cui
Journal:  Cell Biol Toxicol       Date:  2022-01-14       Impact factor: 6.691

3.  Use of Telemedicine in the Diagnosis of Cervical Spondylotic Myelopathy in a US Veteran During the COVID-19 Pandemic: A Case Report.

Authors:  Alyssa Troutner; Michael Barbato
Journal:  J Chiropr Med       Date:  2022-07-16

4.  Brain Structural and Functional Dissociated Patterns in Degenerative Cervical Myelopathy: A Case-Controlled Retrospective Resting-State fMRI Study.

Authors:  Yi Zhou; Jiaqi Shi
Journal:  Front Neurol       Date:  2022-06-15       Impact factor: 4.086

5.  National Trends in Demographics and Outcomes Following Cervical Fusion for Cervical Spondylotic Myelopathy.

Authors:  Caroline E Vonck; Joseph E Tanenbaum; Gabriel A Smith; Edward C Benzel; Thomas E Mroz; Michael P Steinmetz
Journal:  Global Spine J       Date:  2017-09-22

6.  Clinical outcomes of epidural and intradural decompression for treatment of degenerative cervical myelopathy.

Authors:  Genlong Jiao; Zhizhong Li; Pan Zhou; Jinpei Yang; Xueshi Li
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

7.  The ratio of the posterior atlanto-occipital interval (PAOI): a novel radiographic ratio method evaluating the risk of cervical spondylotic myelopathy-a case-control study.

Authors:  Mingsheng Tan; Jipeng Song; Yanlei Wang; Long Gong; Yan Sun; Ping Yi; Feng Yang; Xiangsheng Tang; Qingying Hao; Wenhao Li
Journal:  Quant Imaging Med Surg       Date:  2021-07

8.  Quantitative Magnetization Transfer MRI Measurements of the Anterior Spinal Cord Region are Associated With Clinical Outcomes in Cervical Spondylotic Myelopathy.

Authors:  Michael Brendan Cloney; Zachary A Smith; Kenneth A Weber; Todd B Parrish
Journal:  Spine (Phila Pa 1976)       Date:  2018-05-15       Impact factor: 3.241

9.  Tract-Specific Volume Loss on 3T MRI in Patients With Cervical Spondylotic Myelopathy.

Authors:  Benjamin S Hopkins; Kenneth A Weber; Michael Brendan Cloney; Monica Paliwal; Todd B Parrish; Zachary A Smith
Journal:  Spine (Phila Pa 1976)       Date:  2018-10-15       Impact factor: 3.241

10.  Comparison of the use of opioids only and pregabalin add-on for the treatment of neuropathic pain in cervical myelopathy patients: a pilot trial.

Authors:  Jong-Myung Jung; Chun Kee Chung; Chi Heon Kim; Seung Heon Yang; Yunhee Choi
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.